Idera Pharmaceuticals reported $5.36M in Operating Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbott ABT:US $ 8869M 114M
Agenus AGEN:US $ 65.49M 4.09M
Alnylam Pharmaceuticals ALNY:US $ 416.5M 56.51M
Amgen AMGN:US $ 4.42B 680M
Biogen BIIB:US $ 2648.2M 727.1M
Biomarin Pharmaceutical BMRN:US $ 494.65M 112.61M
Cytrx CYTR:US 1.29M 7.73M
Dynavax Technologies DVAX:US $ 128.24M 45.01M
Eli Lilly And LLY:US $ 5277.9M 127.8M
Gilead Sciences GILD:US $ 4231M 2162M
GlaxoSmithKline GSK:LN 584.8B 95.1B
Idera Pharmaceuticals IDRA:US $ 5.36M 1.18M
Merk MRK:US $ 9666M 666M
Mirati Therapeutics MRTX:US $ 182.57M 2.36M
Nektar Therapeutics NKTR:US $ 174.42M 33.04M
Pfizer PFE:US $ 15640M 148M
Sarepta Therapeutics SRPT:US $ 444.62M 146.91M
Seattle Genetics SGEN:US $ 630.61M 71.1M
Ultragenyx Pharmaceutical RARE:US $ 230.94M 14.37M